Familial Lipoprotein Lipase Deficiency
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Familial Lipoprotein Lipase Deficiency

What is the definition of Familial Lipoprotein Lipase Deficiency?

Familial lipoprotein lipase deficiency is an inherited condition that disrupts the normal breakdown of fats in the body, resulting in an increase of certain kinds of fats.

What are the causes of Familial Lipoprotein Lipase Deficiency?

Mutations in the LPL gene cause familial lipoprotein lipase deficiency. The LPL gene provides instructions for producing an enzyme called lipoprotein lipase, which is found primarily on the surface of cells that line tiny blood vessels (capillaries) within muscles and fatty (adipose) tissue. This enzyme helps break down fats called triglycerides, which are carried by molecules called lipoproteins.

How prevalent is Familial Lipoprotein Lipase Deficiency?

This condition affects about 1 per million people worldwide. It is much more common in certain areas of the province of Quebec, Canada.

Is Familial Lipoprotein Lipase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Familial Lipoprotein Lipase Deficiency Local Doctors?
Elite in Familial Lipoprotein Lipase Deficiency
Elite in Familial Lipoprotein Lipase Deficiency
Referral may be required
Montreal, QC, CA 

Daniel Gaudet practices practicing medicine in Montreal, Canada. Mr. Gaudet is rated as an Elite expert by MediFind in the treatment of Familial Lipoprotein Lipase Deficiency. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypertriglyceridemia, Familial Lipoprotein Lipase Deficiency, and Apolipoprotein C2 Deficiency.

Elite in Familial Lipoprotein Lipase Deficiency
Elite in Familial Lipoprotein Lipase Deficiency
Referral may be required
Chicoutimi, QC, CA 

Diane Brisson practices practicing medicine in Chicoutimi, Canada. Ms. Brisson is rated as an Elite expert by MediFind in the treatment of Familial Lipoprotein Lipase Deficiency. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, High Cholesterol, and Familial Hypertriglyceridemia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Familial Lipoprotein Lipase Deficiency
Endocrinology
Elite in Familial Lipoprotein Lipase Deficiency
Endocrinology
Referral required

Office

9500 Gilman Dr # 719, 
La Jolla, CA 
Languages Spoken:
English
Accepting New Patients

Joseph Witztum is an Endocrinologist practicing medicine in La Jolla, California. Dr. Witztum is rated as an Elite provider by MediFind in the treatment of Familial Lipoprotein Lipase Deficiency. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, Familial Hypertriglyceridemia, and Antigen-Peptide-Transporter 2 Deficiency. Dr. Witztum is currently accepting new patients.

What are the latest Familial Lipoprotein Lipase Deficiency Clinical Trials?
An Open-Label Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Pediatric Patients With Familial Chylomicronemia Syndrome (FCS)

Summary: The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia: a Randomized, Double-blind, Placebo-controlled Trial

Summary: Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high. It is caused by lack of certain enzymes and proteins in the bodythat are important in disposing circulating fats from blood. Treatment of T1HLP patients who have very high levels of blood fats (≥ 1,000 mg/dL) is challenging as conventional...

Who are the sources who wrote this article ?

Published Date: February 01, 2015
Published By: National Institutes of Health